In the last 12 months, insiders at Sotera Health Co ($SHC) filed 127 transactions with the SEC: 0 open-market purchases totaling $0 and 25 sales totaling $3,533,249,880. Net insider sentiment: net selling.
Sotera Health Co operates in the Services-misc health & allied services, nec industry (Industrial Applications and Services sector).
Most Active Insiders
- WARBURG PINCUS & CO. (Director) — 10 transactions totaling $2,309,947,697
- GTCR INVESTMENT XI LLC (Not found) — 4 transactions totaling $567,218,400
- WARBURG PINCUS & CO. (Not found) — 2 transactions totaling $317,455,200
- GTCR INVESTMENT XI LLC (Director) — 2 transactions totaling $308,582,556
- Petras Michael B. Jr. (Chairman & CEO) — 29 transactions totaling $32,846,511
View all SEC Filings for Sotera Health Co (SHC).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | DIMITRIEF ALEXANDER | Former SVP, GC and Sec. | F | Common Stock, $0.01 par value per share ("Common Stock") | 7941 | $14.34 | 312,040.0000 | 286,745,000 | 2.48% | 0.00% |
| March 6, 2026 | GTCR INVESTMENT XI LLC | Not found | S | Common Stock, $0.01 par value per share ("Common Stock") | 10000000 | $15.27 | 12,735,301.0000 | 286,745,000 | 43.98% | 3.49% |
| March 6, 2026 | WARBURG PINCUS & CO. | Director | S | Common Stock, $0.01 par value per share ("Common Stock") | 15000000 | $15.27 | 19,102,952.0000 | 286,745,000 | 43.98% | 5.23% |
| March 6, 2026 | WARBURG PINCUS & CO. | Director | S | Common Stock, $0.01 par value per share ("Common Stock") | 15000000 | $15.27 | 19,102,952.0000 | 286,745,000 | 43.98% | 5.23% |
| March 2, 2026 | Petras Michael B. Jr. | Chairman & CEO | M | Common Stock | 89686 | $0.00 | 5,390,228.0000 | 286,745,000 | 1.69% | 0.03% |
| March 2, 2026 | Petras Michael B. Jr. | Chairman & CEO | F | Common Stock | 40302 | $15.91 | 5,300,542.0000 | 286,745,000 | 0.75% | 0.01% |
| March 2, 2026 | Petras Michael B. Jr. | Chairman & CEO | F | Common Stock | 39552 | $15.91 | 5,350,676.0000 | 286,745,000 | 0.73% | 0.01% |
| March 2, 2026 | Petras Michael B. Jr. | Chairman & CEO | F | Common Stock | 79104 | $15.91 | 5,271,572.0000 | 286,745,000 | 1.48% | 0.03% |
| March 2, 2026 | Petras Michael B. Jr. | Chairman & CEO | A | Common Stock | 240248 | $0.00 | 5,511,820.0000 | 286,745,000 | 4.56% | 0.08% |
| March 2, 2026 | Petras Michael B. Jr. | Chairman & CEO | M | Share Appreciation Units | 89686 | $0.00 | 59,790.0000 | 286,745,000 | 60.00% | 0.03% |
| March 2, 2026 | Petras Michael B. Jr. | Chairman & CEO | A | Share Appreciation Units | 120124 | $0.00 | 120,124.0000 | 286,745,000 | 9999.99% | 0.04% |
| March 2, 2026 | DIMITRIEF ALEXANDER | SVP, General Counsel and Sec. | F | Common Stock, $0.01 par value per share ("Common Stock") | 7941 | $15.91 | 326,784.0000 | 286,745,000 | 2.37% | 0.00% |
| March 2, 2026 | DIMITRIEF ALEXANDER | SVP, General Counsel and Sec. | M | Common Stock | 16816 | $0.00 | 343,600.0000 | 286,745,000 | 5.15% | 0.01% |
| March 2, 2026 | DIMITRIEF ALEXANDER | SVP, General Counsel and Sec. | F | Common Stock | 23619 | $15.91 | 319,981.0000 | 286,745,000 | 6.87% | 0.01% |
| March 2, 2026 | DIMITRIEF ALEXANDER | SVP, General Counsel and Sec. | M | Performance RSUs | 16816 | $0.00 | 11,210.0000 | 286,745,000 | 60.00% | 0.01% |
| March 2, 2026 | Lyons Jonathan M. | Sr. Vice President, CFO | F | Common Stock, $0.01 par value per share ("Common Stock") | 6046 | $15.91 | 183,556.0000 | 286,745,000 | 3.19% | 0.00% |
| March 2, 2026 | Lyons Jonathan M. | Sr. Vice President, CFO | M | Common Stock | 17937 | $0.00 | 201,493.0000 | 286,745,000 | 9.77% | 0.01% |
| March 2, 2026 | Lyons Jonathan M. | Sr. Vice President, CFO | F | Common Stock | 23988 | $15.91 | 177,505.0000 | 286,745,000 | 11.91% | 0.01% |
| March 2, 2026 | Lyons Jonathan M. | Sr. Vice President, CFO | F | Common Stock | 8240 | $15.91 | 169,265.0000 | 286,745,000 | 4.64% | 0.00% |
| March 2, 2026 | Lyons Jonathan M. | Sr. Vice President, CFO | A | Common Stock | 59355 | $0.00 | 228,620.0000 | 286,745,000 | 35.07% | 0.02% |
| March 2, 2026 | Lyons Jonathan M. | Sr. Vice President, CFO | M | Performance RSUs | 17937 | $0.00 | 11,958.0000 | 286,745,000 | 60.00% | 0.01% |
| March 2, 2026 | Lyons Jonathan M. | Sr. Vice President, CFO | A | Performance RSUs | 29678 | $0.00 | 29,678.0000 | 286,745,000 | 9999.99% | 0.01% |
| March 2, 2026 | Rutz Michael P | President of Sterigenics | F | Common Stock, $0.01 par value per share ("Common Stock") | 3729 | $15.91 | 446,475.0000 | 286,745,000 | 0.83% | 0.00% |
| March 2, 2026 | Rutz Michael P | President of Sterigenics | F | Common Stock | 4495 | $15.91 | 441,980.0000 | 286,745,000 | 1.01% | 0.00% |
| March 2, 2026 | Rutz Michael P | President of Sterigenics | M | Common Stock | 14573 | $0.00 | 456,553.0000 | 286,745,000 | 3.30% | 0.01% |
| March 2, 2026 | Rutz Michael P | President of Sterigenics | F | Common Stock | 17497 | $15.91 | 439,056.0000 | 286,745,000 | 3.83% | 0.01% |
| March 2, 2026 | Rutz Michael P | President of Sterigenics | A | Common Stock | 45223 | $0.00 | 484,279.0000 | 286,745,000 | 10.30% | 0.02% |
| March 2, 2026 | Rutz Michael P | President of Sterigenics | M | Performance RSUs | 14573 | $0.00 | 9,716.0000 | 286,745,000 | 60.00% | 0.01% |
| March 2, 2026 | Rutz Michael P | President of Sterigenics | A | Performance RSUs | 22612 | $0.00 | 22,612.0000 | 286,745,000 | 9999.99% | 0.01% |
| March 2, 2026 | Petras Michael B. Jr. | Chairman & CEO | F | Common Stock, $0.01 par value per share ("Common Stock") | 31339 | $15.91 | 521,451.0000 | 286,745,000 | 5.67% | 0.01% |
| Dec. 8, 2025 | Petras Michael B. Jr. | Chairman & CEO | S | Common Stock, $0.01 par value per share ("Common Stock") | 315896 | $16.45 | 552,790.0000 | 286,745,000 | 36.36% | 0.11% |
| Dec. 8, 2025 | Petras Michael B. Jr. | Chairman & CEO | S | Common Stock | 39243 | $16.45 | 4,819,393.0000 | 286,745,000 | 0.81% | 0.01% |
| Dec. 8, 2025 | Petras Michael B. Jr. | Chairman & CEO | S | Common Stock | 394861 | $16.45 | 4,819,393.0000 | 286,745,000 | 7.57% | 0.14% |
| Dec. 3, 2025 | WARBURG PINCUS & CO. | Not found | S | Common Stock, $0.01 par value per share ("Common Stock") | 9720000 | $16.33 | 34,102,952.0000 | 286,745,000 | 22.18% | 3.39% |
| Dec. 3, 2025 | WARBURG PINCUS & CO. | Not found | S | Common Stock, $0.01 par value per share ("Common Stock") | 9720000 | $16.33 | 34,102,952.0000 | 286,745,000 | 22.18% | 3.39% |
| Dec. 3, 2025 | GTCR INVESTMENT XI LLC | Not found | S | Common Stock, $0.01 par value per share ("Common Stock") | 6480000 | $16.33 | 22,735,301.0000 | 286,745,000 | 22.18% | 2.26% |
| Nov. 10, 2025 | WARBURG PINCUS & CO. | Director | S | Common Stock, $0.01 par value per share ("Common Stock") | 18000000 | $15.65 | 43,822,952.0000 | 286,745,000 | 29.12% | 6.28% |
| Nov. 10, 2025 | GTCR INVESTMENT XI LLC | Not found | S | Common Stock, $0.01 par value per share ("Common Stock") | 12000000 | $15.65 | 29,215,301.0000 | 286,745,000 | 29.12% | 4.18% |
| Nov. 10, 2025 | WARBURG PINCUS & CO. | Director | S | Common Stock, $0.01 par value per share ("Common Stock") | 18000000 | $15.65 | 43,822,952.0000 | 286,745,000 | 29.12% | 6.28% |
| Sept. 5, 2025 | WARBURG PINCUS & CO. | Director | S | Common Stock, $0.01 par value per share ("Common Stock") | 12000000 | $15.11 | 61,822,952.0000 | 284,906,000 | 16.26% | 4.21% |
| Sept. 5, 2025 | GTCR INVESTMENT XI LLC | Not found | S | Common Stock, $0.01 par value per share ("Common Stock") | 8000000 | $15.11 | 41,215,301.0000 | 284,906,000 | 16.26% | 2.81% |
| Sept. 5, 2025 | WARBURG PINCUS & CO. | Director | S | Common Stock, $0.01 par value per share ("Common Stock") | 12000000 | $15.11 | 61,822,952.0000 | 284,906,000 | 16.26% | 4.21% |
| Aug. 22, 2025 | Rutz Michael P | President of Sterigenics | S | Common Stock | 126611 | $16.38 | 450,204.0000 | 284,906,000 | 21.95% | 0.04% |
| Aug. 5, 2025 | Lyons Jonathan M. | Sr. Vice President, CFO | F | Common Stock, $0.01 par value per share ("Common Stock") | 11508 | $11.19 | 189,602.0000 | 284,906,000 | 5.72% | 0.00% |
| May 22, 2025 | MIHAS CONSTANTINE S | Not found | A | Common Stock, $0.01 par value per share ("Common Stock") | 19132 | $0.00 | 80,781.0000 | 284,906,000 | 31.03% | 0.01% |
| May 22, 2025 | PETRELLA VINCENT K | Not found | A | Common Stock, $0.01 par value per share ("Common Stock") | 19132 | $0.00 | 80,781.0000 | 284,906,000 | 31.03% | 0.01% |
| May 22, 2025 | Wheadon David E. | Not found | A | Common Stock, $0.01 par value per share ("Common Stock") | 19132 | $0.00 | 74,912.0000 | 284,906,000 | 34.30% | 0.01% |
| May 22, 2025 | Knauss Robert Brown | Not found | A | Common Stock, $0.01 par value per share ("Common Stock") | 19132 | $0.00 | 54,933.0000 | 284,906,000 | 53.44% | 0.01% |
| May 22, 2025 | Flynn Karen | Not found | A | Common Stock, $0.01 par value per share ("Common Stock") | 19132 | $0.00 | 39,221.0000 | 284,906,000 | 95.24% | 0.01% |
| May 22, 2025 | Simon, Christopher | Not found | A | Common Stock, $0.01 par value per share ("Common Stock") | 19132 | $0.00 | 19,132.0000 | 284,906,000 | 9999.99% | 0.01% |
| May 22, 2025 | Chen Ruoxi | Not found | A | Common Stock, $0.01 par value per share ("Common Stock") | 19132 | $0.00 | 80,781.0000 | 284,906,000 | 31.03% | 0.01% |
| May 22, 2025 | CUNNINGHAM SEAN LAURENCE | Not found | A | Common Stock, $0.01 par value per share ("Common Stock") | 19132 | $0.00 | 80,781.0000 | 284,906,000 | 31.03% | 0.01% |
| May 22, 2025 | Klee Ann R. | Not found | A | Common Stock, $0.01 par value per share ("Common Stock") | 19132 | $0.00 | 125,956.0000 | 284,906,000 | 17.91% | 0.01% |
| May 22, 2025 | Neary James | Not found | A | Common Stock, $0.01 par value per share ("Common Stock") | 19132 | $0.00 | 80,781.0000 | 284,906,000 | 31.03% | 0.01% |
| March 3, 2025 | Petras Michael B. Jr. | Chairman & CEO | A | Performance Stock Units | 149476 | $0.00 | 149,476.0000 | 284,906,000 | 9999.99% | 0.05% |
| March 2, 2025 | Petras Michael B. Jr. | Chairman & CEO | F | Common Stock, $0.01 par value per share ("Common Stock") | 27990 | $12.47 | 642,509.0000 | 284,906,000 | 4.17% | 0.01% |
| March 2, 2025 | Petras Michael B. Jr. | Chairman & CEO | F | Common Stock | 31872 | $12.47 | 5,864,217.0000 | 284,906,000 | 0.54% | 0.01% |
| March 2, 2025 | Petras Michael B. Jr. | Chairman & CEO | F | Common Stock | 40987 | $12.47 | 5,823,230.0000 | 284,906,000 | 0.70% | 0.01% |
| March 3, 2025 | Petras Michael B. Jr. | Chairman & CEO | A | Common Stock | 298953 | $0.00 | 6,122,183.0000 | 284,906,000 | 5.13% | 0.10% |
| March 2, 2025 | Rutz Michael P | President of Sterigenics | F | Common Stock, $0.01 par value per share ("Common Stock") | 3687 | $12.47 | 537,833.0000 | 284,906,000 | 0.68% | 0.00% |
| March 2, 2025 | Rutz Michael P | President of Sterigenics | F | Common Stock | 4198 | $12.47 | 533,635.0000 | 284,906,000 | 0.78% | 0.00% |
| March 2, 2025 | Rutz Michael P | President of Sterigenics | F | Common Stock | 5399 | $12.47 | 528,236.0000 | 284,906,000 | 1.01% | 0.00% |
| March 3, 2025 | Rutz Michael P | President of Sterigenics | A | Common Stock | 48579 | $0.00 | 576,815.0000 | 284,906,000 | 9.20% | 0.02% |
| March 3, 2025 | Rutz Michael P | President of Sterigenics | A | Performance RSUs | 24289 | $0.00 | 24,289.0000 | 284,906,000 | 9999.99% | 0.01% |
| March 2, 2025 | Lyons Jonathan M. | Sr. Vice President, CFO | F | Common Stock, $0.01 par value per share ("Common Stock") | 6481 | $12.47 | 103,951.0000 | 284,906,000 | 5.87% | 0.00% |
| March 3, 2025 | Lyons Jonathan M. | Sr. Vice President, CFO | A | Common Stock | 59790 | $0.00 | 163,741.0000 | 284,906,000 | 57.52% | 0.02% |
| March 3, 2025 | Lyons Jonathan M. | Sr. Vice President, CFO | A | Common Stock | 37369 | $0.00 | 201,110.0000 | 284,906,000 | 22.82% | 0.01% |
| March 3, 2025 | Lyons Jonathan M. | Sr. Vice President, CFO | A | Performance RSUs | 29895 | $0.00 | 29,895.0000 | 284,906,000 | 9999.99% | 0.01% |
| March 2, 2025 | DIMITRIEF ALEXANDER | SVP, General Counsel and Sec. | F | Common Stock, $0.01 par value per share ("Common Stock") | 8211 | $12.47 | 278,672.0000 | 284,906,000 | 2.86% | 0.00% |
| March 3, 2025 | DIMITRIEF ALEXANDER | SVP, General Counsel and Sec. | A | Common Stock | 56053 | $0.00 | 334,725.0000 | 284,906,000 | 20.11% | 0.02% |
| March 3, 2025 | DIMITRIEF ALEXANDER | SVP, General Counsel and Sec. | A | Performance RSUs | 28026 | $0.00 | 28,026.0000 | 284,906,000 | 9999.99% | 0.01% |
| Nov. 20, 2024 | Petras Michael B. Jr. | Chairman & CEO | F | Common Stock, $0.01 par value per share ("Common Stock") | 29250 | $13.21 | 5,924,079.0000 | 285,564,000 | 0.49% | 0.01% |
| Nov. 20, 2024 | Rutz Michael P | President of Sterigenics | F | Common Stock, $0.01 par value per share ("Common Stock") | 2889 | $13.21 | 541,520.0000 | 285,564,000 | 0.53% | 0.00% |
| Nov. 22, 2024 | Petras Michael B. Jr. | Chairman & CEO | G | Common Stock, $0.01 par value per share ("Common Stock") | 39243 | $0.00 | 5,924,079.0000 | 285,564,000 | 0.67% | 0.01% |
| Nov. 22, 2024 | Petras Michael B. Jr. | Chairman & CEO | G | Common Stock, $0.01 par value per share ("Common Stock") | 39243 | $0.00 | 5,924,079.0000 | 285,564,000 | 0.66% | 0.01% |
| Sept. 10, 2024 | Petras Michael B. Jr. | Chairman & CEO | G | Common Stock, $0.01 par value per share ("Common Stock") | 200000 | $0.00 | 5,953,329.0000 | 283,222,000 | 3.25% | 0.07% |
| Sept. 6, 2024 | GTCR INVESTMENT XI LLC | Director | S | Common Stock, $0.01 par value per share ("Common Stock") | 10000000 | $15.03 | 49,215,301.0000 | 283,222,000 | 16.89% | 3.53% |
| Sept. 6, 2024 | WARBURG PINCUS & CO. | Director | S | Common Stock, $0.01 par value per share ("Common Stock") | 15000000 | $15.03 | 73,822,952.0000 | 283,222,000 | 16.89% | 5.30% |
| Sept. 6, 2024 | WARBURG PINCUS & CO. | Director | S | Common Stock, $0.01 par value per share ("Common Stock") | 15000000 | $15.03 | 73,822,952.0000 | 283,222,000 | 16.89% | 5.30% |
| Aug. 5, 2024 | Lyons Jonathan M. | Sr. Vice President, CFO | F | Common Stock, $0.01 par value per share ("Common Stock") | 7659 | $14.22 | 110,432.0000 | 283,222,000 | 6.49% | 0.00% |
| May 24, 2024 | Flynn Karen | Not found | A | Common Stock, $0.01 par value per share ("Common Stock") | 20089 | $0.00 | 20,089.0000 | 283,222,000 | 9999.99% | 0.01% |
| May 24, 2024 | Knauss Robert Brown | Not found | A | Common Stock, $0.01 par value per share ("Common Stock") | 20089 | $0.00 | 35,801.0000 | 283,222,000 | 127.86% | 0.01% |
| May 24, 2024 | Wheadon David E. | Not found | A | Common Stock, $0.01 par value per share ("Common Stock") | 20089 | $0.00 | 55,780.0000 | 283,222,000 | 56.29% | 0.01% |
| May 24, 2024 | PETRELLA VINCENT K | Not found | A | Common Stock, $0.01 par value per share ("Common Stock") | 20089 | $0.00 | 61,649.0000 | 283,222,000 | 48.34% | 0.01% |
| May 24, 2024 | Neary James | Not found | A | Common Stock, $0.01 par value per share ("Common Stock") | 20089 | $0.00 | 61,649.0000 | 283,222,000 | 48.34% | 0.01% |
| May 24, 2024 | MIHAS CONSTANTINE S | Not found | A | Common Stock, $0.01 par value per share ("Common Stock") | 20089 | $0.00 | 61,649.0000 | 283,222,000 | 48.34% | 0.01% |
| May 24, 2024 | Klee Ann R. | Not found | A | Common Stock, $0.01 par value per share ("Common Stock") | 20089 | $0.00 | 106,824.0000 | 283,222,000 | 23.16% | 0.01% |
| May 24, 2024 | Donnini David | Not found | A | Common Stock, $0.01 par value per share ("Common Stock") | 20089 | $0.00 | 61,649.0000 | 283,222,000 | 48.34% | 0.01% |
| May 24, 2024 | Chen Ruoxi | Not found | A | Common Stock, $0.01 par value per share ("Common Stock") | 20089 | $0.00 | 61,649.0000 | 283,222,000 | 48.34% | 0.01% |
| May 24, 2024 | CUNNINGHAM SEAN LAURENCE | Not found | A | Common Stock, $0.01 par value per share ("Common Stock") | 20089 | $0.00 | 61,649.0000 | 283,222,000 | 48.34% | 0.01% |
| March 4, 2024 | GTCR INVESTMENT XI LLC | Director | S | Common Stock, $0.01 par value per share ("Common Stock") | 11062908 | $14.31 | 59,215,301.0000 | 283,222,000 | 15.74% | 3.91% |
| March 4, 2024 | WARBURG PINCUS & CO. | Director | S | Common Stock, $0.01 par value per share ("Common Stock") | 16594363 | $14.31 | 88,822,952.0000 | 283,222,000 | 15.74% | 5.86% |
| March 4, 2024 | Lyons Jonathan M. | Sr. Vice President, CFO | A | Stock Options | 81676 | $0.00 | 115,316.0000 | 283,222,000 | 242.79% | 0.03% |
| March 4, 2024 | DIMITRIEF ALEXANDER | SVP, General Counsel and Sec. | A | Common Stock, $0.01 par value per share ("Common Stock") | 51405 | $0.00 | 286,883.0000 | 283,222,000 | 21.83% | 0.02% |
| March 4, 2024 | DIMITRIEF ALEXANDER | SVP, General Counsel and Sec. | A | Stock Options | 102095 | $0.00 | 704,482.0000 | 283,222,000 | 16.95% | 0.04% |
| March 4, 2024 | Klee Ann R. | Not found | S | Common Stock, $0.01 par value per share ("Common Stock") | 5750 | $14.31 | 86,735.0000 | 283,222,000 | 6.22% | 0.00% |
| March 4, 2024 | Lyons Jonathan M. | Sr. Vice President, CFO | A | Common Stock, $0.01 par value per share ("Common Stock") | 41124 | $0.00 | 118,091.0000 | 283,222,000 | 53.43% | 0.01% |
| March 4, 2024 | WARBURG PINCUS & CO. | Director | S | Common Stock, $0.01 par value per share ("Common Stock") | 16594363 | $14.31 | 88,822,952.0000 | 283,222,000 | 15.74% | 5.86% |
| March 2, 2024 | Rutz Michael P | President of Sterigenics | F | Common Stock, $0.01 par value per share ("Common Stock") | 2438 | $14.56 | 596,311.0000 | 283,222,000 | 0.41% | 0.00% |
| March 4, 2024 | Petras Michael B. Jr. | Chairman & CEO | S | Common Stock, $0.01 par value per share ("Common Stock") | 1003870 | $14.31 | 6,153,329.0000 | 283,222,000 | 14.03% | 0.35% |
| March 4, 2024 | Petras Michael B. Jr. | Chairman & CEO | A | Common Stock, $0.01 par value per share ("Common Stock") | 274160 | $0.00 | 6,153,329.0000 | 283,222,000 | 4.66% | 0.10% |
| March 2, 2024 | Petras Michael B. Jr. | Chairman & CEO | F | Common Stock, $0.01 par value per share ("Common Stock") | 21574 | $14.56 | 5,879,169.0000 | 283,222,000 | 0.37% | 0.01% |
| March 2, 2024 | Petras Michael B. Jr. | Chairman & CEO | F | Common Stock, $0.01 par value per share ("Common Stock") | 27990 | $14.56 | 5,900,743.0000 | 283,222,000 | 0.47% | 0.01% |
| March 4, 2024 | Rutz Michael P | President of Sterigenics | A | Stock Options | 68063 | $0.00 | 297,600.0000 | 283,222,000 | 29.65% | 0.02% |
| March 4, 2024 | Rutz Michael P | President of Sterigenics | S | Common Stock, $0.01 par value per share ("Common Stock") | 83109 | $14.31 | 544,409.0000 | 283,222,000 | 13.24% | 0.03% |
| March 4, 2024 | Rutz Michael P | President of Sterigenics | A | Common Stock, $0.01 par value per share ("Common Stock") | 34270 | $0.00 | 627,518.0000 | 283,222,000 | 5.78% | 0.01% |
| March 2, 2024 | Rutz Michael P | President of Sterigenics | F | Common Stock, $0.01 par value per share ("Common Stock") | 3063 | $14.56 | 593,248.0000 | 283,222,000 | 0.51% | 0.00% |
| March 4, 2024 | Petras Michael B. Jr. | Chairman & CEO | A | Stock Options | 544509 | $0.00 | 4,653,903.0000 | 283,222,000 | 13.25% | 0.19% |
| Nov. 20, 2023 | Rutz Michael P | President of Sterigenics | F | Common Stock, $0.01 par value per share ("Common Stock") | 1911 | $13.93 | 598,749.0000 | 280,096,000 | 0.32% | 0.00% |
| Nov. 20, 2023 | Petras Michael B. Jr. | Chairman & CEO | F | Common Stock, $0.01 par value per share ("Common Stock") | 29250 | $13.93 | 555,418.0000 | 280,096,000 | 5.00% | 0.01% |
| Aug. 7, 2023 | Lyons Jonathan M. | Sr. Vice President, CFO | A | Stock Options | 33640 | $0.00 | 33,640.0000 | 280,096,000 | 9999.99% | 0.01% |
| Aug. 7, 2023 | Lyons Jonathan M. | Sr. Vice President, CFO | A | Common Stock, $0.01 par value per share (Common Stock) | 76967 | $0.00 | 76,967.0000 | 280,096,000 | 9999.99% | 0.03% |
| May 26, 2023 | Klee Ann R. | Director | A | Common Stock, $0.01 par value per share (Common Stock) | 15712 | $0.00 | 92,485.0000 | 280,096,000 | 20.47% | 0.01% |
| May 26, 2023 | Donnini David | Director | A | Common Stock, $0.01 par value per share (Common Stock) | 15712 | $0.00 | 41,560.0000 | 280,096,000 | 60.79% | 0.01% |
| May 26, 2023 | Knauss Robert Brown | Director | A | Common Stock, $0.01 par value per share (Common Stock) | 15712 | $0.00 | 15,712.0000 | 280,096,000 | 9999.99% | 0.01% |
| May 26, 2023 | MIHAS CONSTANTINE S | Director | A | Common Stock, $0.01 par value per share (Common Stock) | 15712 | $0.00 | 41,560.0000 | 280,096,000 | 60.79% | 0.01% |
| May 26, 2023 | Neary James | Director | A | Common Stock, $0.01 par value per share (Common Stock) | 15712 | $0.00 | 41,560.0000 | 280,096,000 | 60.79% | 0.01% |
| May 26, 2023 | PETRELLA VINCENT K | Director | A | Common Stock, $0.01 par value per share (Common Stock) | 15712 | $0.00 | 41,560.0000 | 280,096,000 | 60.79% | 0.01% |
| May 26, 2023 | Wheadon David E. | Director | A | Common Stock, $0.01 par value per share (Common Stock) | 15712 | $0.00 | 35,691.0000 | 280,096,000 | 78.64% | 0.01% |
| May 26, 2023 | Chen Ruoxi | Director | A | Common Stock, $0.01 par value per share (Common Stock) | 15712 | $0.00 | 41,560.0000 | 280,096,000 | 60.79% | 0.01% |
| May 26, 2023 | CUNNINGHAM SEAN LAURENCE | Director | A | Common Stock, $0.01 par value per share (Common Stock) | 15712 | $0.00 | 41,560.0000 | 280,096,000 | 60.79% | 0.01% |
| March 6, 2023 | Rutz Michael P | President of Sterigenics | A | Common Stock, $0.01 par value per share ("Common Stock") | 28425 | $0.00 | 600,660.0000 | 280,096,000 | 4.97% | 0.01% |
| March 6, 2023 | Rutz Michael P | President of Sterigenics | A | Stock Options | 53879 | $0.00 | 229,537.0000 | 280,096,000 | 30.67% | 0.02% |
| March 6, 2023 | Petras Michael B. Jr. | Chairman & CEO | A | Common Stock, $0.01 par value per share ("Common Stock") | 213189 | $0.00 | 584,668.0000 | 280,096,000 | 57.39% | 0.08% |
| March 6, 2023 | Petras Michael B. Jr. | Chairman & CEO | A | Stock Options | 404094 | $0.00 | 4,109,394.0000 | 280,096,000 | 10.91% | 0.14% |
| March 2, 2023 | Petras Michael B. Jr. | Chairman & CEO | F | Common Stock, $0.01 par value per share ("Common Stock") | 19841 | $17.41 | 371,479.0000 | 280,096,000 | 5.07% | 0.01% |
| March 2, 2023 | Rutz Michael P | President of Sterigenics | F | Common Stock, $0.01 par value per share ("Common Stock") | 2948 | $17.41 | 572,235.0000 | 280,096,000 | 0.51% | 0.00% |